Patent · US Active

Modified nucleosides or nucleotides

US9593373B2 · kind B2 · utility

30Cited by

27References

20Claims

0Family size

Assignee

Illumina Cambridge Limited · GB

Inventors

Xiaohai Liu · Saffron Walden, GB
Xiaolin Wu · Saffron Walden, GB
Geoffrey Paul Smith · Cambridge, GB

Key dates

Filing date	Mar 15, 2013
Grant date	Mar 14, 2017
Priority date	—
Expiry date	Mar 15, 2033

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/55
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Some embodiments described herein relate to modified nucleotide and nucleoside molecules with novel 3′-hydroxy protecting groups. Also provided herein are methods to prepare such modified nucleotide and nucleoside molecules and sequencing by synthesis processes using such modified nucleotide and nucleoside molecules.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.